419 results on '"Wever-Pinzon, Omar"'
Search Results
2. Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices
3. Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy
4. Health-related Quality of Life as a predictor of Heart Failure Admission and Death in Patients with Amyloidosis PC41 (#284)
5. Bridge‐to‐transplant temporary mechanical circulatory support and risk of allosensitization
6. Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
7. Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation
8. Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support
9. Abstract 11629: Multicenter Development and Validation of a Machine Learning Risk Model to Predict Right Ventricular Failure Following Mechanical Circulatory Support: The STOP-RVF Score
10. Abstract 11588: Multicenter Development and Validation of a Machine Learning Model to Predict Myocardial Recovery During LVAD Support: The UCAR Score
11. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.
12. Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices
13. Complication Rates Of Temporary Mechanical Circulatory Support In Patients With Cardiogenic Shock
14. Cumulative long-term efficacy and safety of mavacamten treatment in nonobstructive hypertrophic cardiomyopathy: updated interim analysis from the MAVERICK cohort of the MAVA-long-term extension (LTE) study up to 120 weeks
15. Health-related Quality Of Life As A Predictor Of Heart Failure Admission And Death In Patients With Amyloidosis
16. Low Seroprevalence of Neutralizing Antibodies to Adeno-Associated Virus Serotype 9 (AAV9) in Preparation for MyPeak-1, the First-in-Human Study of TN-201, an Investigational AAV9-Mediated Gene Therapy for Individuals with MYBPC3-Associated Hypertrophic Cardiomyopathy (HCM)
17. Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
18. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices
19. Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF Score.
20. The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure
21. Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed
22. Machine Learning Identification Of Transcriptomics And Clinical Characteristics Associated With Myocardial Recovery In Heart Failure Patients Undergoing Mechanical Circulatory Support
23. HEALTH RELATED QUALITY OF LIFE AS PREDICTOR OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
24. IMPAIRED LIVER FUNCTION IS ASSOCIATED WITH HYPOTENSION AND ELEVATED RIGHT ATRIAL PRESSURE BUT NOT DEPRESSED CARDIAC INDEX IN CHRONIC HEART FAILURE
25. Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow
26. Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy
27. Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept
28. Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support: The Utah Bleeding Risk Score
29. Team-based Care for Advanced Heart Failure
30. Non-invasive assessment of low risk acute chest pain in the emergency department: A comparative meta-analysis of prospective studies
31. Mechanical Unloading and Heart Remodeling Features
32. Supportive Cardiac Magnetic Resonance Imaging (CMR) Features for Differentiating Hypertrophic Cardiomyopathy and Cardiac Amyloidosis.
33. Biology of myocardial recovery in advanced heart failure with long-term mechanical support
34. Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy
35. Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation
36. Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation
37. Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support
38. The Heart Transplant Waiting List and the Interplay of Policy and Practice: In Search of Fairness
39. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation
40. Allograft Rejection Surveillance In Heart Transplantation: Is There a Better Way?
41. Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database
42. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
43. Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin–Angiotensin System Inhibitors
44. Prognostic Value of Stress Echocardiogram in Patients With Angiographically Significant Coronary Artery Disease
45. Predicting Cardiac Structural And Functional Improvement On Left Ventricular Assist Device Support: The Externally Validated UCAR Score
46. Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device
47. Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions after LVAD
48. PDE3 inhibition in dilated cardiomyopathy
49. Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report
50. Abstract 9685: Long-Term Efficacy and Safety of Mavacamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Interim Results from the MAVERICK-LTE Cohort of the MAVA-LTE Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.